Cellular Intelligence · Series A

Foundation models for human stem cells to industrialize cell therapy production

Amount

$47M

Round

Series A

Valuation

—

Announced

May 2025

Investors

Lead investor

Khosla Ventures

Participating investors

Harpoon Ventures TechAviv Fusion Fund SciFi VC Chan Zuckerberg Initiative Ajinomoto Group Ventures Pitango HealthTech R. Martin Chavez Fidji Simo